CompletedNCT06166095
Dose-Response Effect Exercise and Depression
This summary needs review. Please check the official study record and contact the research team for details.
In OrlandoDepressionOtherFrom 18 Years to 25 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT01793610
Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD
This summary needs review. Please check the official study record and contact the research team for details.
In BoulderPTSDDrugA study involving a medication or substance.Over 18 Years
CompletedNCT00580125
Safety study of Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in schizophrenia
This study is completed in the United States, in India, in Russia, .... It is testing Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo for schizophrenia.
Multiple locations, including Garden GroveSchizophreniaDrugOver 18 Years
CompletedNCT05966766
Dosing Music for Anxiety Reduction in Parturients
This summary needs review. Please check the official study record and contact the research team for details.
In BostonAnxietyOtherOver 18 Years
CompletedNCT00527683
Double Blind Study of Vigabatrin for Cocaine Dependence
This summary needs review. Please check the official study record and contact the research team for details.
In Mexico CityAddictionBehavioralFrom 18 Years to 55 Years
CompletedNCT01041092
Double Blind, Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women
This study is completed in Spain. It is testing raloxifene for schizophrenia.
In Esplugues de LlobregatSchizophreniaDrugOver 40 Years
CompletedNCT01121042
Double Blind, Investigation of Ondansetron in Schizophrenia
This study is completed in Australia. It is testing Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron for schizophrenia.
In MelbourneSchizophreniaDrugFrom 18 Years to 65 Years
TerminatedNCT00570063
Double Blind, 3 Week Inpatient Study Safety & Efficacy Of PF-02545920 Compared With Placebo
This study was terminated in the United States. It focuses on Schizophrenia.
Multiple locations, including GlendaleSchizophreniaDrugFrom 18 Years to 99 Years
CompletedEUCTR 2008-001417-26
Double blind, mulitcentric study relapse prevention of a hypericum extract in outdoor people with moderate depressive episodes (major depr...
This study is completed in Germany. It focuses on depression.
In GermanyDepressionOther
CompletedNCT00632229
Double Blinded, study of Paliperidone Addition in SRI-Resistant OCD
This study is completed in the United States. It focuses on OCD.
Multiple locations, including St. PetersburgOCDDrugFrom 18 Years to 70 Years
CompletedNCT02251743
2-Site study of Neurofeedback for ADHD
This study is completed in the United States. It is testing Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD.
Multiple locations, including AshevilleADHDDeviceA study involving a tool, app, wearable, test, or medical device.From 7 Years to 10 Years
CompletedNCT02185131
Study of Mirtazapine for Co-occurring AD/MDD.
This study is completed in the United States. It focuses on Depression.
In PittsburghDepression, AddictionDrugFrom 18 Years to 55 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.